{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:46:18Z","timestamp":1794980778438,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","award":["2022-LCYJ-MS-36"],"award-info":[{"award-number":["2022-LCYJ-MS-36"]}],"id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870695"],"award-info":[{"award-number":["81870695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20201114"],"award-info":[{"award-number":["BK20201114"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008832","name":"Nanjing Municipal Health Bureau","doi-asserted-by":"publisher","award":["ZKX20022"],"award-info":[{"award-number":["ZKX20022"]}],"id":[{"id":"10.13039\/501100008832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04292-8","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:54:18Z","timestamp":1745427258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A first-in-human, prospective pilot trial of umbilical cord-derived mesenchymal stem cell eye drops therapy for patients with refractory non-Sj\u00f6gren's and Sj\u00f6gren's syndrome dry eye disease"],"prefix":"10.1186","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct05784519","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Di","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taige","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"5","key":"4292_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jama.2021.19963","volume":"327","author":"FE Hakim","year":"2022","unstructured":"Hakim FE, Farooq AV. Dry eye disease: an update in 2022. JAMA. 2022;327(5):478\u20139.","journal-title":"JAMA"},{"key":"4292_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ajo.2019.01.026","volume":"202","author":"R Dana","year":"2019","unstructured":"Dana R, Bradley JL, Guerin A, Pivneva I, Stillman I, Evans AM, et al. Estimated prevalence and incidence of dry eye disease based on coding analysis of a large, all-age united states health care system. Am J Ophthalmol. 2019;202:47\u201354.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"4292_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438\u2013510.","journal-title":"Ocul Surf"},{"issue":"1","key":"4292_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biom14010080","volume":"14","author":"KY Wu","year":"2024","unstructured":"Wu KY, Serhan O, Faucher A, Tran SD. Advances in Sj\u00f6gren\u2019s syndrome dry eye diagnostics: biomarkers and biomolecules beyond clinical symptoms. Biomolecules. 2024;14(1):80.","journal-title":"Biomolecules"},{"key":"4292_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtos.2021.05.006","volume":"21","author":"MK Morthen","year":"2021","unstructured":"Morthen MK, Magno MS, Utheim TP, Snieder H, Hammond CJ, Vehof J. The physical and mental burden of dry eye disease: A large population-based study investigating the relationship with health-related quality of life and its determinants. Ocul Surf. 2021;21:107\u201317.","journal-title":"Ocul Surf"},{"key":"4292_CR6","doi-asserted-by":"publisher","first-page":"1305579","DOI":"10.3389\/fmed.2024.1305579","volume":"11","author":"CW Lin","year":"2024","unstructured":"Lin CW, Lin MY, Huang JW, Wang TJ, Lin IC. Impact of dry eye disease treatment on patient quality of life. Front Med (Lausanne). 2024;11:1305579.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"4292_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/07853890.2022.2157477","volume":"55","author":"J Sheppard","year":"2023","unstructured":"Sheppard J, Shen Lee B, Periman LM. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Ann Med. 2023;55(1):241\u201352.","journal-title":"Ann Med"},{"issue":"8","key":"4292_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/aos.15159","volume":"100","author":"L Hynnekleiv","year":"2022","unstructured":"Hynnekleiv L, Magno M, Vernhardsdottir RR, Moschowits E, T\u00f8nseth KA, Dartt DA, et al. Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol. 2022;100(8):844\u201360.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"4292_CR9","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.4103\/IJO.IJO_2818_22","volume":"71","author":"A Kate","year":"2023","unstructured":"Kate A, Shanbhag SS, Donthineni PR, Amescua G, Quinones VLP, Basu S. Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease. Indian J Ophthalmol. 2023;71(4):1176\u201389.","journal-title":"Indian J Ophthalmol"},{"issue":"10","key":"4292_CR10","first-page":"15070","volume":"10","author":"SH Liu","year":"2022","unstructured":"Liu SH, Saldanha IJ, Abraham AG, Rittiphairoj T, Hauswirth S, Gregory D, et al. Topical corticosteroids for dry eye. Cochrane Database Syst Rev. 2022;10(10):15070.","journal-title":"Cochrane Database Syst Rev"},{"key":"4292_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.732887","volume":"12","author":"L Yu","year":"2021","unstructured":"Yu L, Yu C, Dong H, Mu Y, Zhang R, Zhang Q, et al. Recent developments about the pathogenesis of dry eye disease: based on immune inflammatory mechanisms. Front Pharmacol. 2021;12: 732887.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4292_CR12","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/ijms24021580","volume":"24","author":"KY Wu","year":"2023","unstructured":"Wu KY, Kulbay M, Tanasescu C, Jiao B, Nguyen BH, Tran SD. An overview of the dry eye disease in sj\u00f6gren\u2019s syndrome using our current molecular understanding. Int J Mol Sci. 2023;24(2):1580.","journal-title":"Int J Mol Sci"},{"key":"4292_CR13","doi-asserted-by":"crossref","unstructured":"Surico PL, Barone V, Singh RB, Coassin M, Blanco T, Dohlman TH, et al. Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders. Surv Ophthalmol. 2024.","DOI":"10.1016\/j.survophthal.2024.07.008"},{"key":"4292_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jtos.2023.09.008","volume":"30","author":"M Soleimani","year":"2023","unstructured":"Soleimani M, Mirshahi R, Cheraqpour K, Baharnoori SM, Massoumi H, Chow C, et al. Intrastromal versus subconjunctival injection of mesenchymal stem\/stromal cells for promoting corneal repair. Ocul Surf. 2023;30:187\u201395.","journal-title":"Ocul Surf"},{"issue":"6","key":"4292_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/14712598.2023.2175605","volume":"23","author":"M Soleimani","year":"2023","unstructured":"Soleimani M, Masoumi A, Momenaei B, Cheraqpour K, Koganti R, Chang AY, et al. Applications of mesenchymal stem cells in ocular surface diseases: sources and routes of delivery. Expert Opin Biol Ther. 2023;23(6):509\u201325.","journal-title":"Expert Opin Biol Ther"},{"key":"4292_CR16","doi-asserted-by":"crossref","unstructured":"Bhujel B, Oh SH, Kim CM, Yoon YJ, Kim YJ, Chung HS, et al. Mesenchymal Stem Cells and Exosomes: A Novel Therapeutic Approach for Corneal Diseases. Int J Mol Sci. 2023;24(13).","DOI":"10.3390\/ijms241310917"},{"key":"4292_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107905","volume":"191","author":"X Lu","year":"2020","unstructured":"Lu X, Li N, Zhao L, Guo D, Yi H, Yang L, et al. Human umbilical cord mesenchymal stem cells alleviate ongoing autoimmune dacryoadenitis in rabbits via polarizing macrophages into an anti-inflammatory phenotype. Exp Eye Res. 2020;191: 107905.","journal-title":"Exp Eye Res"},{"key":"4292_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100967","volume":"85","author":"JY Oh","year":"2021","unstructured":"Oh JY, Lee RH. Mesenchymal stromal cells for the treatment of ocular autoimmune diseases. Prog Retin Eye Res. 2021;85: 100967.","journal-title":"Prog Retin Eye Res"},{"key":"4292_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jtos.2020.11.013","volume":"19","author":"M M\u00f8ller-Hansen","year":"2021","unstructured":"M\u00f8ller-Hansen M, Larsen AC, Toft PB, Lynggaard CD, Schwartz C, Bruunsgaard H, et al. Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye disease. Ocul Surf. 2021;19:43\u201352.","journal-title":"Ocul Surf"},{"key":"4292_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtos.2023.11.007","volume":"31","author":"M M\u00f8ller-Hansen","year":"2024","unstructured":"M\u00f8ller-Hansen M, Larsen AC, Wiencke AK, Terslev L, Siersma V, Andersen TT, et al. Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sj\u00f6gren\u2019s syndrome: a randomized clinical trial. Ocul Surf. 2024;31:1\u20138.","journal-title":"Ocul Surf"},{"issue":"2","key":"4292_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","volume":"24","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular Drug Delivery: a Comprehensive Review. AAPS PharmSciTech. 2023;24(2):66.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"4292_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539\u201374.","journal-title":"Ocul Surf"},{"issue":"1","key":"4292_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American college of rheumatology\/European league against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9\u201316.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4292_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19971","volume":"9","author":"R Guo","year":"2023","unstructured":"Guo R, Jiang J, Zhang Y, Liang Q, Liu J, Hu K. The effects of chalazion and the excision surgery on the ocular surface. Heliyon. 2023;9(9): e19971.","journal-title":"Heliyon"},{"issue":"1","key":"4292_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13287-020-01696-6","volume":"11","author":"Y Xie","year":"2020","unstructured":"Xie Y, Liu W, Liu S, Wang L, Mu D, Cui Y, et al. The quality evaluation system establishment of mesenchymal stromal cells for cell-based therapy products. Stem Cell Res Ther. 2020;11(1):176.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4292_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/jcm11010066","volume":"11","author":"M Hata-Mizuno","year":"2021","unstructured":"Hata-Mizuno M, Uchino Y, Uchino M, Shimmura S, Ogawa Y, Tsubota K, et al. Analysis of the association between galectin-3 concentration in tears and the severity of dry eye disease: a case-control study. J Clin Med. 2021;11(1):66.","journal-title":"J Clin Med"},{"issue":"4","key":"4292_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/aos.15629","volume":"101","author":"CJ Jackson","year":"2023","unstructured":"Jackson CJ, Naqvi M, Gundersen KG, Utheim TP. Role of stem cells in regenerative treatment of dry eye disease caused by lacrimal gland dysfunction. Acta Ophthalmol. 2023;101(4):360\u201375.","journal-title":"Acta Ophthalmol"},{"issue":"277","key":"4292_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/aos.15739","volume":"101","author":"M M\u00f8ller-Hansen","year":"2023","unstructured":"M\u00f8ller-Hansen M. Mesenchymal stem cell therapy in aqueous deficient dry eye disease. Acta Ophthalmol. 2023;101(277):3\u201327.","journal-title":"Acta Ophthalmol"},{"key":"4292_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108115","volume":"197","author":"SC Pflugfelder","year":"2020","unstructured":"Pflugfelder SC, Stern ME. Biological functions of tear film. Exp Eye Res. 2020;197: 108115.","journal-title":"Exp Eye Res"},{"issue":"1","key":"4292_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S, Bootsma H, De Vita S, D\u00f6rner T, et al. EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79(1):3\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4292_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383.","journal-title":"Ocul Surf"},{"issue":"4","key":"4292_CR32","first-page":"301","volume":"126","author":"J Vehof","year":"2020","unstructured":"Vehof J, Utheim TP, Bootsma H, Hammond CJ. Advances, limitations and future perspectives in the diagnosis and management of dry eye in Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2020;126(4):301\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"4292_CR33","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.4103\/IJO.IJO_2981_22","volume":"71","author":"NR Kumar","year":"2023","unstructured":"Kumar NR, Praveen M, Narasimhan R, Khamar P, D\u2019Souza S, Sinha-Roy A, et al. Tear biomarkers in dry eye disease: progress in the last decade. Indian J Ophthalmol. 2023;71(4):1190\u2013202.","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"4292_CR34","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1038\/s41598-020-59956-7","volume":"10","author":"KS Khimani","year":"2020","unstructured":"Khimani KS, Go JA, De Souza RG, Mitchell T, Yu Z, de Paiva CS, et al. Regional comparison of goblet cell number and area in exposed and covered dry eyes and their correlation with tear MUC5AC. Sci Rep. 2020;10(1):2933.","journal-title":"Sci Rep"},{"issue":"5","key":"4292_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233517","volume":"15","author":"R Mani","year":"2020","unstructured":"Mani R, Shobha PS, Thilagavathi S, Prema P, Viswanathan N, Vineet R, et al. Altered mucins and aquaporins indicate dry eye outcome in patients undergoing Vitreo-retinal surgery. PLoS ONE. 2020;15(5): e0233517.","journal-title":"PLoS ONE"},{"key":"4292_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.973962","volume":"13","author":"H Yu","year":"2022","unstructured":"Yu H, Zeng W, Zhao G, Hong J, Feng Y. Response of tear cytokines following intense pulsed light combined with meibomian gland expression for treating meibomian gland dysfunction-related dry eye. Front Endocrinol (Lausanne). 2022;13: 973962.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"4292_CR37","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.4103\/IJO.IJO_2851_22","volume":"71","author":"R Kannan","year":"2023","unstructured":"Kannan R, Das S, Shetty R, Zhou L, Ghosh A, Deshpande V. Tear proteomics in dry eye disease. Indian J Ophthalmol. 2023;71(4):1203\u201314.","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"4292_CR38","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/mas.21691","volume":"41","author":"E Ponzini","year":"2022","unstructured":"Ponzini E, Santambrogio C, De Palma A, Mauri P, Tavazzi S, Grandori R. Mass spectrometry-based tear proteomics for noninvasive biomarker discovery. Mass Spectrom Rev. 2022;41(5):842\u201360.","journal-title":"Mass Spectrom Rev"},{"key":"4292_CR39","first-page":"8","volume":"20","author":"MT Kuo","year":"1932","unstructured":"Kuo MT, Fang PC, Chao TL, Chen A, Lai YH, Huang YT, et al. 2019 tear proteomics approach to monitoring sj\u00f6gren syndrome or dry eye disease. Int J Mol Sci. 1932;20:8.","journal-title":"Int J Mol Sci"},{"key":"4292_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jtos.2022.03.001","volume":"24","author":"CJ Jackson","year":"2022","unstructured":"Jackson CJ, Gundersen KG, Tong L, Utheim TP. Dry eye disease and proteomics. Ocul Surf. 2022;24:119\u201328.","journal-title":"Ocul Surf"},{"key":"4292_CR41","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.csbj.2024.04.033","volume":"23","author":"J Nourisa","year":"2024","unstructured":"Nourisa J, Passemiers A, Shakeri F, Omidi M, Helmholz H, Raimondi D, et al. Gene regulatory network analysis identifies MYL1, MDH2, GLS, and TRIM28 as the principal proteins in the response of mesenchymal stem cells to Mg(2+) ions. Comput Struct Biotechnol J. 2024;23:1773\u201385.","journal-title":"Comput Struct Biotechnol J"},{"key":"4292_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131193","volume":"389","author":"S Zhang","year":"2023","unstructured":"Zhang S, Yang L, Guo S, Hu F, Cheng D, Sun J, et al. Mannose binding lectin-associated serine protease-1 is a novel contributor to myocardial ischemia\/reperfusion injury. Int J Cardiol. 2023;389: 131193.","journal-title":"Int J Cardiol"},{"issue":"1","key":"4292_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/jor.25348","volume":"41","author":"C Sun","year":"2023","unstructured":"Sun C, Cao C, Zhao T, Guo H, Fleming BC, Owens B, et al. A2M inhibits inflammatory mediators of chondrocytes by blocking IL-1\u03b2\/NF-\u03baB pathway. J Orthop Res. 2023;41(1):241\u20138.","journal-title":"J Orthop Res"},{"issue":"5","key":"4292_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/0004563217750679","volume":"55","author":"P Versura","year":"2018","unstructured":"Versura P, Giannaccare G, Vukatana G, Mul\u00e8 R, Malavolta N, Campos EC. Predictive role of tear protein expression in the early diagnosis of Sj\u00f6gren\u2019s syndrome. Ann Clin Biochem. 2018;55(5):561\u201370.","journal-title":"Ann Clin Biochem"},{"issue":"15","key":"4292_CR45","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1167\/iovs.19-27872","volume":"60","author":"YW Ji","year":"2019","unstructured":"Ji YW, Kim HM, Ryu SY, Oh JW, Yeo A, Choi CY, et al. Changes in human tear proteome following topical treatment of dry eye disease: cyclosporine a versus diquafosol tetrasodium. Invest Ophthalmol Vis Sci. 2019;60(15):5035\u201344.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4292_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jtos.2023.04.015","volume":"29","author":"GT Jung","year":"2023","unstructured":"Jung GT, Kim M, Song JS, Kim TI, Chung TY, Choi CY, et al. Proteomic analysis of tears in dry eye disease: a prospective, double-blind multicenter study. Ocul Surf. 2023;29:68\u201376.","journal-title":"Ocul Surf"},{"key":"4292_CR47","doi-asserted-by":"crossref","unstructured":"Bazzoni R, Takam Kamga P, Tanasi I, Krampera M. Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells. Front Cell Dev Biol. 2020;8:596079.","DOI":"10.3389\/fcell.2020.596079"},{"key":"4292_CR48","doi-asserted-by":"crossref","unstructured":"Guo R, Liang Q, He Y, Wang C, Jiang J, Chen T, et al. Mesenchymal Stromal Cells-Derived Extracellular Vesicles Regulate Dendritic Cell Functions in Dry Eye Disease. Cells. 2022;12(1).","DOI":"10.3390\/cells12010033"},{"issue":"11","key":"4292_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.64.11.3","volume":"64","author":"X Zhao","year":"2023","unstructured":"Zhao X, Li N, Yang N, Mi B, Dang W, Sun D, et al. Thymosin \u03b24 alleviates autoimmune dacryoadenitis via suppressing Th17 cell response. Invest Ophthalmol Vis Sci. 2023;64(11):3.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4292_CR50","doi-asserted-by":"publisher","first-page":"1307682","DOI":"10.3389\/fmed.2024.1307682","volume":"11","author":"L Chu","year":"2024","unstructured":"Chu L, Wang C, Zhou H. Inflammation mechanism and anti-inflammatory therapy of dry eye. Front Med (Lausanne). 2024;11:1307682.","journal-title":"Front Med (Lausanne)"},{"key":"4292_CR51","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jtos.2020.05.009","volume":"19","author":"NW Fan","year":"2021","unstructured":"Fan NW, Dohlman TH, Foulsham W, McSoley M, Singh RB, Chen Y, et al. The role of Th17 immunity in chronic ocular surface disorders. Ocul Surf. 2021;19:157\u201368.","journal-title":"Ocul Surf"},{"issue":"1","key":"4292_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41385-020-0289-3","volume":"14","author":"Y Chen","year":"2021","unstructured":"Chen Y, Shao C, Fan NW, Nakao T, Amouzegar A, Chauhan SK, et al. The functions of IL-23 and IL-2 on driving autoimmune effector T-helper 17 cells into the memory pool in dry eye disease. Mucosal Immunol. 2021;14(1):177\u201386.","journal-title":"Mucosal Immunol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04292-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04292-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04292-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:03:23Z","timestamp":1745431403000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04292-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4292"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04292-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee, all patients provided written informed consent before the procedure. The Ethical approval details are as follows: Title: Study on the curative effect of mesenchymal stem cell eye drops on dry eye disease. The institutional approval committee: Medical Ethics Committee of Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School. Approval number: SC202200102. Date of approval: 01 June, 2022. The human umbilical cord-derived MSCs utilized in this study were procured from the Clinical Stem Cell Center at Nanjing Drum Tower Hospital. As previously documented [], ethical clearance was obtained from the Medical Ethics Committees of Nanjing Drum Tower Hospital for the project titled \"Utilization of Clinical Patient Samples (Tissue\/Blood\/Body Fluids) and Aborted Fetal Tissue to Extract Stem Cells for Basic and Clinical Research in Regenerative Medicine and Treatment of Clinical Diseases\" (Approval No. 2017\u2013161-08; Approval Date: November 30, 2017). Informed consent forms were signed by all donors prior to sample collection, ensuring adherence to ethical guidelines for research involving human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients gave consent for the publication of the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have not use AI-generated work in this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial intelligence"}}],"article-number":"202"}}